Dr. George is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Elm And Carlton St
Buffalo, NY 14263Phone+1 716-845-2300Fax+1 716-845-3423
Summary
- Dr. Saby George is an oncologist in Buffalo, NY and is affiliated with multiple hospitals in the area, including Cleveland Clinic, Miami Valley Hospital, and Roswell Park Comprehensive Cancer Center. He received his medical degree from Kottayam Medical College and has been in practice 18 years. He specializes in genitourinary oncology and hematologic oncology and is experienced in Urologic oncology with a particular research focus on Kidney cancer, prostate cancer, and bladder cancer.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2010
Cleveland Clinic FoundationFellowship, Experimental Therapeutics In Medical Oncology, 2006 - 2008
Wright State UniversityResidency, Internal Medicine, 2003 - 2006
Kottayam Medical CollegeClass of 1999
Certifications & Licensure
OH State Medical License 2003 - 2027
NY State Medical License 2010 - 2025- American Board of Internal Medicine Medical Oncology
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
Clinical Trials
- Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer Start of enrollment: 2006 Oct 01
- Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer Start of enrollment: 2009 Oct 29
- Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery Start of enrollment: 2010 Feb 06
- Join now to see all
Publications & Presentations
PubMed
- TROPHY-U-01 Cohort 2: A Phase II Study of Sacituzumab Govitecan in Cisplatin-Ineligible Patients With Metastatic Urothelial Cancer Progressing After Previous Checkpoin...Daniel P Petrylak, Scott T Tagawa, Rohit K Jain, Manojkumar Bupathi, Arjun Balar
Journal of Clinical Oncology. 2024-10-10 - 1 citationsThree- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S...Mamta Parikh, Catherine Tangen, Maha H A Hussain, Shilpa Gupta, Sam Callis
European Urology Oncology. 2024-10-01 - 1 citationsSafety and effectiveness of the radium-223-taxane treatment sequence in patients with metastatic castration-resistant prostate cancer in a global observational study (...Celestia S Higano, Sabina Dizdarevic, John Logue, Timothy Richardson, Saby George
Cancer. 2024-06-01
Press Mentions
Targeted Combination Shows Promise in Metastatic Kidney CancerNovember 13th, 2024- Roswell Park-Designed Treatment Regimen Doubles Progression-Free Survival in Metastatic Kidney CancerSeptember 15th, 2024
- Are Subcutaneous Drugs the Key to Cancer Care’s Future?August 20th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
